Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
In patients with metastatic castration-resistant Prostate Cancer (BRCA m), the combination of Androgen Receptor (AR) antagonists / Androgen receptor inhibitors / Antiandrogens + PARPs (Poly(ADP-Ribose) Polymerases) Inhibitors has emerged as one of the most robust evidence-based treatment strategies. The most significant benefit is consistently observed in BRCA1/2-altered disease, as opposed to unselected HRR or HRR-proficient populations.
see also:
Prostate Cancer (BRCA m) & Drugs/Treatments
…